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 Abstract 
 Background: Factors influencing outcome after cerebral artery occlusion are not completely 
understood. Although it is well accepted that the site of arterial occlusion critically influences 
outcome, the majority of studies investigating this issue has focused on proximal large artery 
occlusion. To gain a better understanding of factors influencing outcome after distal large 
artery occlusion, we sought to assess predictors of outcome following isolated M2 middle 
cerebral artery occlusion infarcts.  Methods: We retrospectively analyzed patients with iso-
lated acute M2 occlusion admitted to a single academic center from January 2010 to August 
2012. Baseline clinical, laboratory imaging, and outcome data were assessed from a prospec-
tively collected database. Factors associated with a modified Rankin Scale (mRS) score  ≤ 2 in 
univariable analyses (p < 0.05) were entered into multivariable logistic regression analysis. The 
Admission National Institutes of Health Stroke Scale (aNIHSS) score, age, and infarct volume 
were also entered as dichotomized variables. Receiver operating characteristic curves were 
plotted to determine the optimal aNIHSS score, infarct volume, and age cut points predicting 
an mRS score  ≤ 2. Optimal thresholds were determined by maximizing the Youden index. Re-
spective multivariable logistic regression analyses were used to identify independent predic-
tors of a good 90-day outcome (mRS score  ≤ 2; primary analysis) as well as 90-day mortality 
(secondary outcome).  Results: 90 patients with isolated M2 occlusion were included in the 
final analyses. Of these, 69% had a good 90-day outcome which was associated with age <80 
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years (p = 0.007), aNIHSS <10 (p = 0.002), and infarct volume  ≤ 26 ml (p < 0.001). Notably, 20% 
of patients (64% of those with a poor outcome) had died by 90 days. Secondary analysis for 
90-day mortality was performed. This analysis indicated that infarct volume >28 ml (OR 11.874, 
95% CI 2.630–53.604, p = 0.001), age >80 years (OR 4.953, 95% CI 1.087–22.563, p = 0.039), 
need for intubation (OR 7.788, 95% CI 1.072–56.604), and history of congestive heart failure 
(OR 5.819, 95% CI 1.140–29.695) were independent predictors of 90-day mortality (20% of all 
included patients).  Conclusion: While the majority of patients with isolated M2 occlusion 
stroke has a good 90-day outcome, a substantial proportion of subjects dies by 90 days, as 
identified by a unique subset of predictors. The knowledge gained from our study may lead 
to an improvement in the prognostic accuracy, clinical management, and resource utilization 
in this patient population.  © 2014 S. Karger AG, Basel 
 Introduction 
 Acute stroke treatment has evolved significantly over the last two decades, which is in 
part due to an improved understanding of factors that determine outcome  [1] . It is now well 
understood that the site of arterial occlusion critically influences outcome following acute 
anterior circulation ischemic stroke  [2, 3] . However, the majority of studies investigating this 
issue has focused on proximal large artery occlusion involving the internal carotid artery 
(ICA) and proximal middle cerebral artery (MCA) as these represent a particular challenge 
for medical management  [2–4] . For example, recanalization following intervention in ICA and 
proximal MCA occlusion has been reported to be generally poor  [2–4] , and has been asso-
ciated with larger infarct volumes and rarely with good functional outcomes (<40%) even in 
affected patients with aggressive interventions  [2–6] . Conversely, distal MCA occlusions have 
been associated with higher rates of recanalization following intervention, smaller infarct 
volumes, and a favorable outcome in the majority of patients (>50%)  [2–4] . Yet, the number 
of investigated patients in these studies was relatively small (n  ≤ 100) and most (>80%) were 
subjected to intravenous (i.v.) or endovascular recanalization approaches. Hence, there 
remains a paucity of information regarding factors modulating outcome following isolated 
distal MCA occlusion.
 Therefore, we sought to investigate predictors of 90-day functional outcome in patients 
with infarction due to isolated M2 segment occlusion. Specifically, we assessed for factors 
associated with a good versus poor 90-day outcome (primary outcome) as well as 90-mortality 
(secondary outcome).
 Methods 
 Study Population 
 This study was a retrospective analysis of our prospective database including consec-
utive acute ischemic stroke patients admitted to a single academic center from January 2010 
to August 2012. Only patients with isolated M2 occlusion on computed tomography angiog-
raphy (CTA) performed at admission were included. 
 All patients underwent head CT or brain magnetic resonance imaging (MRI) within 7 
days after ischemic stroke. Patient demographics, comorbidities, preadmission medications, 
laboratory data, intubation, requirement for admission at the intensive care unit (ICU), length 
of hospital stay (LOS), treatment modality [conservative management vs. acute intervention 
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Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification]  [7] after completion of 
diagnostic evaluation were collected in all patients. Admission National Institutes of Health 
Stroke Scale (aNIHSS) and modified Rankin Scale (mRS) scores were assessed at the time of 
presentation and at 90 days by a stroke-trained physician or study nurse certified in mRS  [8] . 
This study was reviewed and approved by our Institutional Review Board.
 Image Review and Analysis 
 CT, CTA, and diffusion-weighted imaging were reviewed independently by study physi-
cians masked to clinical data, follow-up scans, patient variables, and outcomes. Details of the 
used imaging protocols have been previously described  [9] . The MCA-M2 segment was 
defined as the segment extending from the bifurcation/trifurcation of the MCA to the top of 
the Sylvian fissure to further division  [10] . The M2 portion was conceptually further divided 
into three segments of equal length: proximal, middle, and distal. The ischemic lesion volume 
was measured manually on follow-up imaging. Hemorrhagic transformation was defined 
according to the European Cooperative Acute Stroke Study II (ECASS II) criteria  [11] . For 
analysis, hemorrhagic transformation was dichotomized into parenchymal hemorrhage (PH) 
versus non-PH. 
 Statistics 
 Continuous variables are reported as mean ± SD or as median ± interquartile range (IQR). 
Categorical variables are reported as proportions. The primary analysis was performed to 
determine factors associated with a good 90-day outcome (mRS 0–2). In light of significant 
mortality, we further sought to investigate for factors that were independently associated 
with 90-day mortality in a secondary analysis. Receiver operating characteristic (ROC) curves 
were plotted to determine the optimal cut point for continuous variables (aNIHSS, age, and 
infarct volume) predicting a good 90-day outcome and mortality, respectively.
 Between-group comparisons for continuous variables were made with unpaired t test, 
Mann-Whitney U test, and Kruskal Wallis with post hoc Dunn’s method. Categorical variables 
were compared using the χ 2 test or Fisher exact test as appropriate. Variables significantly 
associated with 90-day outcome in the univariable analysis (p < 0.05) were included in the 
multivariable logistic regression model with backward elimination (likelihood ratio) to 
identify independent predictors for a good 90-day outcome or 90-day mortality, respectively.
 Two-sided significance tests were used throughout and p < 0.05 was considered statisti-
cally significant. All statistical analyses were performed using IBM ® SPSS ® Statistics 20.0.0 
(IBM ® , Armonk, N.Y., USA).
 Results 
 During the study period, 1,269 patients were admitted for acute ischemic stroke. Of 
these, 202 patients had an MCA occlusion confirmed by imaging and 106 of them had an 
occlusion distal to the bifurcation. Sixteen patients with an M3 occlusion were excluded. Thus, 
90 patients with isolated M2 occlusions were included for analysis ( fig. 1 ).
 Primary Analysis 
 The majority of patients (69%) had a good 90-day outcome ( fig. 2 ). Baseline character-
istics of the included patients as stratified by good (mRS score  ≤ 2) versus poor (mRS score 
>2) outcome are summarized in  table 1 . In univariable analysis ( table 1 ), factors associated 
with a poor 90-day outcome were older age (p = 0.014), a higher aNIHSS (p < 0.001), admission 
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proximal M2 occlusion (p = 0.024), greater infarct volume (p < 0.001), presence of both 
cortical and subcortical infarcts (p = 0.004), and PH-type conversion (p = 0.036). ROC curve 
analyses indicated that an aNIHSS  ≤ 10 (sensitivity = 0.836, specificity = 0.931, AUC = 0.917, 
p < 0.001), age  ≤ 80 years (sensitivity = 0.721, specificity = 0.690, AUC = 0.673, p = 0.008), and 
infarct volume  ≤ 26 ml (sensitivity = 0.902, specificity = 0.862, AUC = 0.925, p < 0.001) best 
predicted a good 90-day outcome.
 Multivariable logistic regression analysis indicated that age  ≤ 80 years (OR 0.045,
95% CI 0.005–0.435, p = 0.007), aNIHSS  ≤ 10 (OR 0.073, 95% CI 0.014–0.387, p = 0.002),
and infarct volume  ≤ 26 ml (OR 0.018, 95% CI 0.002–0.166, p < 0.001) were significant 
predic tors of good 90-day outcome (mRS score 0–2) ( table 2 ). When aNIHSS, age, and infarct 
volume were entered as continuous variables, multivariable analysis showed that a low-
er aNIHSS and smaller infarct volume (p = 0.001) were independently associated with
a good 90-day outcome (online suppl. table 1; for all online suppl. material, see www.
karger.com/doi/10.1159/000360075).
 Secondary Analysis 
 In contrast to the overall good outcome in our patient cohort, a significant proportion of 
patients with a poor outcome (64%) had died by 90 days. In secondary analyses, we sought 
Ischemic stroke (n = 1,269)
Without MCA occlusions (n = 1,067)
MCA occlusions (n = 202)
With (M1) MCA occlusions on CTA (n = 96)
Distal MCA occlusions (n = 106)
With M3 occlusions (n = 16)
Isolated M2 occlusions (n = 90) Fig. 1. Flowchart showing the 
process of patient selection for in-









 Fig. 2. Distribution of the 90-day 
mRS score. The majority of our 
cohort patients achieved func-
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 Table 1.  Baseline characteristics (unadjusted) of the studied patient population as stratified by good 90-day outcome (mRS 
score 0 – 2)
Characteristics All patients 
(n = 90)
Good outcome 
(mRS 0 – 2; n = 61)
Poor outcome 
(mRS 3 – 6; n = 29)
p value
Age, years 73 ± 15 70 ± 16 78 ± 13 0.014
Female sex 50 (55.6) 31 (50.8) 19 (65.5) n.s.
Median aNIHSS (IQR) 8 (4 – 16) 6.8 (4 – 8) 18 (12 – 24) <0.001
Final TOAST stroke mechanisms n.s.
Large artery atherosclerosis 8 (9) 7 (11.5) 1 (3.4)
Cardioembolic stroke 49 (54) 31 (51) 18 (62)
Stroke of other/undetermined cause 32 (36) 22 (36) 10 (34.5)
Acute intervention n.s.
Conservative management 67 (74) 45 (74) 22 (76)
i.v. rtPA 23 (26) 16 (26) 7 (24)
Endovascular intervention* 5 (5.6) 5 (8.2) 0 (0) 
Imaging data
Final infarct volume, ml 28 ± 32 12.5 ± 14.7 60.4 ± 35 <0.001
PH type conversion 5 (5.6) 1 (1.6) 4 (14) 0.036
Proximal M2 occlusion 37 (41) 20 (33) 17 (59) 0.024
Cortical plus subcortical infarction 11 (12) 3 (5) 8 (28) 0.004
Serum markers
HbA1c 6.3 ± 1.1 6.4 ± 1.1 6.3 ± 1.2 n.s.
Glucose at admission, mg/dl 140 ± 55 140 ± 57 141 ± 50 n.s.
Creatinine at admission, mg/dl 1.06 ± 0.51 1.1 ± 0.37 1.14 ± 0.69 n.s.
White blood cells at admission, ×103/μl 8.6 ± 2.7 8.4 ± 2.9 9.3 ± 2.2 n.s.
LDL-C, mg/dl 93 ± 38 97 ± 39 85 ± 36 n.s.
HDL-C, mg/dl 46 ± 15 45 ± 14 48 ± 16 n.s.
Preadmission medications
Antiplatelets 40 (44) 30 (49) 10 (34) n.s.
Oral anticoagulation 9 (10) 6 (10) 3 (10) n.s.
Statin 30 (33) 20 (33) 10 (34) n.s.
Antiglycemic 19 (21) 15 (250) 4 (14) n.s.
Antihypertensive 57 (63) 38 (62) 19 (66) n.s.
Preexisting risk factors
Hypertension 71 (79) 47 (77) 24 (83) n.s.
Dyslipidemia 51 (56) 37 (60) 14 (48) n.s.
Diabetes 31 (34) 24 (39) 7 (24) n.s.
Prior stroke or transient ischemic attack 13 (14) 8 (13) 5 (17) n.s.
Atrial fibrillation 28 (31) 17 (28) 11 (38) n.s.
Coronary artery disease 27 (30) 17 (28) 10 (34) n.s.
Congestive heart failure 18 (20) 9 (15) 9 (31) n.s.
Renal failure 2 (2) 1 (2) 1 (3) n.s.
Cancer 7 (8) 5 (8) 2 (7) n.s.
Peripheral vascular disease 6 (7) 6 (10) 0 (0) n.s.
Current smoking 22 (24) 18 (29) 4 (14) n.s.
Alcohol abuse 7 (8) 5 (8.2) 2 (7) n.s.
Admission at ICU 61 (68) 35 (58) 26 (90) 0.002
Intubation 12 (13) 3 (5) 9 (31) 0.001
Length of  stay, days 4 (2 – 6) 3 (2 – 5) 6 (3 – 11) 0.003
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to investigate for potential unique predictors of mortality. Baseline characteristics of patients 
as stratified by mortality are shown in online supplementary table 2. Older age (p = 0.011), 
congestive heart failure (CHF) (p = 0.007), higher aNIHSS (p < 0.001), ICU admission (p = 
0.009), intubation (p = 0.002), LOS (p = 0.026), proximal M2 occlusion (p = 0.017), greater 
infarct volume (p < 0.001), and presence of both cortical and subcortical infarcts (p = 0.039) 
were predictors of 90-day mortality. ROC curve analyses indicated that an aNIHSS >10 (sensi-
tivity = 0.944, specificity = 0.722, AUC = 0.852, p < 0.001), age >80 years (sensitivity = 0.778, 
specificity = 0.681, AUC = 0.685, p = 0.015), and infarct volume of >28 ml (sensitivity = 0.833, 
specificity = 0.806, AUC = 0.877, p < 0.001) best predicted 90-day mortality (online suppl. 
table 2).
 Multivariable analysis showed that an infarct volume >28 ml (OR 11.874, 95% CI 2.630–
53.604, p = 0.001) and age >80 years (OR 4.953, 95% CI 1.087–22.563, p = 0.039) were inde-
pendently associated with 90-day mortality ( table 3 ). In addition, need for intubation (OR 
7.788, 95% CI 1.072–56.604) and history of CHF (OR 5.819, 95% CI 1.140–29.695) emerged 
as unique predictors of 90-day mortality ( table 3 ). When infarct volume, aNIHSS, and age 
were entered as continuous variables, need for intubation (p = 0.009) and CHF (p = 0.036) 
remained significantly associated with 90-day mortality (online suppl. table 3).
 Discussion 
 In this observational cohort study of stroke patients with M2 occlusions, we found that 
functional outcomes predominantly fall in two extremes. While most patients will have a 
good functional outcome by 90 days, the majority of patients with a poor outcome will have 
died by that time point. The former observation adds to the notion that patients with M2 
occlusion have a generally favorable outcome. Prior studies on patients receiving intra-
venous thrombolysis and/or endovascular therapy showed high recanalization rates and 
good outcomes in 50–70% of cases  [2–4, 12–14] . However, since the majority of studied 
patients received i.v. recombinant tissue plasminogen activator (rtPA), it is difficult to 
extrapolate these findings to patients that are ineligible to systemic (or endovascular) recan-
Independent variable Coefficient (95% CI) p value
Infarct volume ≥26 ml 0.018 (0.002 – 0.166) <0.001
aNIHSS ≥10* 0.073 (0.014 – 0.387) 0.002
Age ≥80 years 0.045 (0.005 – 0.435) 0.007
* When entered as continuous variables, the results did not 
meaningfully change.
Independent variable Coefficient (95% CI) p value
Infarct volume ≥28 ml 11.874 (2.630 – 53.604) 0.001
CHF 5.819 (1.140 – 29.695) 0.034
Age ≥80 years 4.953 (1.087 – 22.563) 0.039
Intubation required 7.788 (1.072 – 56.604) 0.043
 Table 2. Multivariable logistic 
regression analysis with 
backward elimination of factors 
independently associated with a 
good 90-day outcome (mRS 
score 0 – 2)
 Table 3. Multivariable logistic 
regression analysis with 
backward elimination of factors 
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alization strategies. Interestingly, despite the fact that  ∼ 75% of patients in our study were 
not subjected to acute recanalization therapy, the good outcome rates were at the upper 
limit of previously published ranges  [2–4, 12–14] . This observation is important because it 
might explain why some studies did not note robust functional improvement with i.v. rtPA 
treatment in patients with distal MCA occlusion  [15–17] . The reasons for overall good 
outcome in untreated patients are likely related to smaller clot burden leading to sponta-
neous recanalization as well as sparing of lenticulostriate arteries, which together results in 
smaller infarct volumes  [5, 6, 12, 17–22] . Our data supports this hypothesis, as surrogate 
markers of a large lesion volume such as proximal M2 occlusion and cortical plus subcortical 
infarction were associated with worse outcome in unadjusted (but not adjusted) analyses. 
More importantly, consistent with other stroke studies, the absolute lesion volume was the 
most significant outcome predictor  [4–6, 19] . In this respect, it is notable that the herein 
defined lesion volume cut point best predicting a favorable outcome was  ≤ 26 ml, which is 
remarkably consistent with previously defined lesion size cutoffs associated with a good 
outcome  [5, 6, 17] .
 In addition to lesion volume, our data confirms the importance of advanced age as well 
as higher aNIHSS as critical determinants of outcome  [23–25] . Specifically, we found that age 
 ≥ 80 years was associated with a worse prognosis consistent with generally worse outcome 
after ischemic stroke in octogenarians.
 Recent endovascular therapy-based trials did not show a significant benefit over i.v. 
thrombolysis with rtPA  [26] . In this respect our findings may provide valuable information 
for a future endovascular trial design as it may help identify and exclude patients that are ‘too 
good’ (or too poor) to be treated. 
 Notably, 64% of patients with a poor outcome had died by 90 days. This is in stark contrast 
to the observed good outcome in >70% of investigated patients. Advanced age, greater infarct 
volume, history of CHF and need for intubations were independently associated with 90-day 
mortality. Thus, our study expands on previous observations by confirming these as important 
risk factors allowing for the identification of a subpopulation of patients with likely very poor 
outcome after isolated M2 occlusion, and thus aid guiding clinicians in patient management 
as well as counseling family members.
 The strengths of our study relate to the analysis of a large and well-defined patient popu-
lation with investigation of prospectively collected variables that have been associated with 
clinical outcome after ischemic stroke as well as masked assessment of data and standardized 
assessment of 90-day outcome in all patients. Our inclusion of a high number of untreated 
patients provides important information regarding the natural history of isolated M2 occlu-
sions. Finally, we included volumetric analyses in our predictive models, which is important 
because infarct volume is increasingly recognized as a key predictor of outcome. The 
prospective collection of a large number of clinically relevant variables contributed to 
improved data quality while limiting the potential for misclassification.
 Limitations of our study relate to its retrospective design. Further, CTA was obtained at 
the treating stroke physician’s discretion, which may have biased the selection of patients 
having worse clinical presentation and outcomes. However, outcome rates were comparable 
to those published as part of prior studies rendering this possibility less likely  [2–4, 12–14] . 
Given our study design and the limited number of patients that received thrombolytic therapy, 
the therapeutic efficacy of rtPAs could not be ascertained in this patient population. Lastly, 
future studies may benefit from assessing the acute lesion volume by defining the Alberta 
Stroke Program Early Computed Tomography Score (ASPECTS), which has the potential for 
risk stratification in the hyperacute setting  [27, 28] .
 In conclusion, this study shows generally good outcome after isolated M2 occlusion and 
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provide novel information regarding unique predictors for mortality in this group of patients 
with otherwise favorable outcome. Such information may aid in risk stratification to help 
with clinical management as well as to counsel patients and their families.
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